Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian carcinoma

Author： Pignata S.   Monfardini S.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.36, Iss.7, 2000-05, pp. : 817-820

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Adjuvant Chemotherapy be used to Treat Breast Cancer in Elderly Patients (>= 70 years of age)?

By Monfardini S.   Perrone F.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1723-1724

Elsevier

Access to resources Recommend Favorite

Should Adjuvant Chemotherapy be used to Treat Breast Cancer in Elderly Patients(>= 70 years of age)?

By Fentiman I.   Monfardini S.   Perrone F.   Balducci L.   Extermann M.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1720-1722

Elsevier

Access to resources Recommend Favorite

Should Adjuvant Chemotherapy be used to Treat Breast Cancer in Elderly Patients (>= 70 years of age)?

By Fentiman I.S.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1722-1723

Elsevier

Access to resources Recommend Favorite

Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

By Ulahannan Susanna V.   Brahmer Julie R.  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 325-337

Informa Healthcare

Access to resources Recommend Favorite

Should patients with advanced sarcomas be treated with chemotherapy?

By Benjamin P.R.S.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 958-962

Elsevier

Access to resources Recommend Favorite